FIELD: medicine.
SUBSTANCE: present group of inventions refers to medicine, namely to neurology, and concerns prevention of cavernous nerve injuries. That is ensured by administering an effective amount of neuregulin.
EFFECT: it provides prevention of damage and disturbed function of cavernous nerves due to neuroprotective and neuro-reducing properties of neuregulin.
12 cl, 7 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USING NEUREGULIN FOR TREATING PERIPHERAL NERVE INJURY | 2010 |
|
RU2575570C2 |
| APPLICATION OF NEUREGULIN FOR TREATMENT OF PERIPHERAL NERVE DAMAGE | 2010 |
|
RU2657770C1 |
| METHOD OF PROVIDING REQUIRED LEVELS OF GLIAL GROWTH FACTOR 2 IN PLASMA | 2009 |
|
RU2530650C2 |
| COMPOSITIONS AND METHODS FOR TREATMENT DURING NON-ACUTE PERIODS FOLLOWING NEUROLOGICAL CNS DAMAGE | 2013 |
|
RU2646507C2 |
| COMPOSITIONS AND METHODS FOR TREATING NON-ACUTE PERIODS FOLLOWING NEUROLOGICAL DAMAGE | 2009 |
|
RU2501564C2 |
| METHOD FOR ACHIEVING DESIRED GLIAL GROWTH FACTOR 2 PLASMA LEVELS | 2014 |
|
RU2687097C2 |
| PHARMACEUTICAL COMPOSITION FOR INDUCTION OF ERECTION IN MEN (VARIANTS) | 1992 |
|
RU2098120C1 |
| APPLICATION OF PEPTIDE GGF2 IN TREATMENT OR PREVENTION OF HEART FAILURE IN MAMMALS | 2009 |
|
RU2536938C2 |
| THERAPEUTIC DOSING OF NEUREGULIN OR ITS SUB-SEQUENCE FOR TREATING OR PREVENTING HEART FAILURE | 2014 |
|
RU2698090C2 |
| METHOD OF SURGICAL TREATMENT OF ERECTILE DYSFUNCTION IN PATIENTS AFTER RADICAL PROSTATECTOMY | 2020 |
|
RU2744052C1 |
